Clinical Trial

Smart Technology Facilitated Patient-centered Venous Thromboembolism Management

Study acronym: SmaVTE-RCT
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated May 31, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Smart technologies, such as wearable devices, mobile technologies, and artificial intelligence, are being investigated for use in health management. These technologies have the potential to be applied in disease pre-warning, decision-making support, health education, and healthcare maintenance. They are expected to address the challenges in managing thrombosis, improve access to high-quality medical resources in various regions, and enhance the development of a network for thrombosis rescue and treatment prevention. The objective of this study is to evaluate the impact of mobile venous thromboembolism application (mVTEA) based patient-centered management of venous thromboembolism (VTE) on patients' perceptions of thromboprophylaxis, in order to enhance clinical practice and establish a foundation of evidence for managing patients with VTE.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-04-01; most recent amendment 2025-05-27.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-05-27
Trial Details
NCT Number NCT06350331
Lead Sponsor Navy General Hospital, Beijing
Conditions Venous Thromboembolism, Digital Health, Health Education
Enrollment 256 participants
Start Date 2024-08-17
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-31